One of the last things Francis Collins, then-director of the National Institutes of Health, did before retiring was to pressure Moderna into delaying the release of its COVID-19 vaccine because he wanted more minorities in its clinical trials.

Moderna’s CEO, Stephane Bancel, was happy to oblige him, saying that diversity “matters more to us than speed.”